| Federated Investors’ Steve Chiavarone Sees New Highs Ahead for Small-Cap Stocks |
| |
|
Despite having already rallied nearly 25% off its December lows, more upside is ahead for the Russell 2000 small-cap index, according to Federated Investors’ Steve Chiavarone
"We really prefer the parts of the market that the market hated back in December, because they were pricing them for recession," Chiavarone said on CNBC's "Trading Nation" last week, naming energy, industrials, and materials as some of the worst hit. "These were all down 25% to 30% on the idea that earnings and the economy as a whole were going to go into recession."
"For us to get bearish, we need to see a deterioration in the fundamentals that would predict a recession—so claims would need to pick up, inflation would surge, housing starts would have to plummet, the yield curve inverted," he said. "Right now those indicators suggest that the earliest we should even consider recession is late 2020, early 2021."
|
|
| |
|
| GSRX Industries (OTCQB: GSRX) Signs Lease for Third Pure and Natural Retail Location |
| |
|
GSRX Industries (OTCQB: GSRX) leased retail space for a new Pure and Natural store location in Nashville, its second outlet in Tennessee. Earlier in the week the company announced construction was underway on a third location in Austin, Texas.
Why It Matters: Pure and Natural retail locations are the brick-and-mortar extensions of the Company's eCommerce platform, GetPureAndNatural.com, and feature the Company's own brand of pure, full-spectrum hemp-based non-THC CBD products that are naturally certified organic. Each Pure and Natural location will carry a broad range of pharmaceutical grade CBD products, including health, wellness, skin care, and pet products.
Whats Next: In addition to a growing network of CBD-focused locations, GSRX is rapidly expanding its operations in retail cannabis dispensaries in Puerto Rico and California. It’s already taken the lead in Puerto Rico, and with several more locations set to open in the coming months, the barrier to entry for competition continues to steepen. Learn more by watching our exclusive interview with GSRX Chairman Christian Briggs: www.redchip.com/events/38/gsrx-industries-webinar/gsrx
Disclosure
GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.
|
|
| |
|
| Spectrum Global (OTCQB: SGSI) Receives $5.8M+ in New Contract Awards |
| |
|
Spectrum Global Solutions (OTCQB: SGSI), a single-source provider of end-to-end next-generation wireless and wireline network solutions and professional services to the service provider (carrier) and corporate enterprise markets, this week announced that year-to-date it has received over $5.8 million in new contract awards to support carrier network upgrades.
Key Quote: “The new orders add to business obtained in 2018 that we have on deck for completion this year. We anticipate that the new contracts—paired with the unique services, solutions, and technology brought into the business through our pending WaveTech merger—will result in greater value to Spectrum Global and the combined entity.” – Roger Ponder, CEO
What’s Next: As previously announced, SGSl’s merger with WaveTech Global Inc. will create a consolidated entity valued at more than $130 million. Upon closing, SGSI intends to file for a name change to WaveTech Global and uplist to Nasdaq under the ticker symbol “WAVE,” subject to filing and approval by Nasdaq and FINRA.
Disclosure
Spectrum Global Solutions (OTCQB: SGSI) is a client of RedChip Companies, Inc. SGSI agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.
|
|
| |
|
| Marker Therapeutics (NASDAQ: MRKR) Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019 |
| |
|
Marker Therapeutics (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, announced updated data from four clinical trials using the Company's multi-antigen targeted T cell (MultiTAA) therapies.
Key Quote: "We continue to be highly encouraged by the clinical results we've seen to date with our MultiTAA therapies. In AML, we believe we are seeing increasing evidence of meaningful therapeutic benefit for patients with limited treatment alternatives. Our MultiTAA therapy appears to be safe and well-tolerated with the potential to mediate a meaningful anti-tumor effect, in addition to demonstrating a compelling correlation between therapeutic responses, with superior in vivo expansion of our T cells." Peter L. Hoang, MRKR President
The Backstory: Marker Therapeutics is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens (i.e., tumor targets) and kill tumor cells expressing those targets.
Disclosure
Marker Therapeutics (NASDAQ: MRKR) is a client of RedChip Companies, Inc. MRKR agreed to pay RedChip Companies, Inc., a monthly cash fee for (4) months of RedChip investor awareness services.
|
|
| |
|
| Advantego (OTCQB: ADGO) Releases New Reporting Requirement for Public Companies |
| |
|
Advantego Corp. (OTCQB: ADGO) announced the release of its Convertible Note Disclosure Report (CNDR), available now to all publicly-held companies, their auditors, and third-party consultants.
Why It Matters: The niche Business Process as a Service (BPaaS) is a cloud-based solution that addresses the reporting requirements of ASC-480 “Distinguishing Liabilities from Equity” which are often very time-consuming and costly endeavors for public reporting companies to complete.
The Backstory: Advantego Corp. designs, develops, and implements digital technology and enterprise software as a specialized Business Process as a Service (BPaaS). The Company’s products and services are developed and delivered through two wholly-owned operating subsidiaries that leverage its proprietary Intelligent Solutions Platform. This platform combines existing data and systems and integrates best-in-class third-party technologies to provide a comprehensive, managed solution that significantly enhances internal operations and marketing efficiency.
Disclosure
Advantego Corp. (OTCQB: ADGO) is a client of RedChip Companies. Advantego Corp. (OTCQB: ADGO) pays RedChip a monthly cash fee for investor awareness services.
|
|
| |
|
| Electra Meccanica (NASDAQ: SOLO) Hosts Factory Grand Opening Ceremony for SOLO Electric Vehicle |
| |
|
Electra Meccanica Vehicles Corp. (NASDAQ: SOLO) expects to produce approximately 50 SOLO EVs in the quarter ended March 31, 2019 as it ramps production considerably over the course of 2019 to deliver a total of 5,000 vehicles by year end.
Key Quote: “I am proud of our strategic partners at Zongshen, who have provided us with a state-of-the-art production facility and a highly-skilled production team to make the Electra Meccanica SOLO EV a reality.” Jerry Kroll, CEO of Electra Meccanica
The Backstory: Electra Meccanica is a designer and manufacturer of electric vehicles. The Company builds the innovative, all-electric SOLO, a single passenger vehicle developed to revolutionize the way people commute, as well as the Tofino, an elegant high-performance two-seater electric roadster sports car. Both vehicles are tuned for the ultimate driving experience while making your commute more efficient, cost-effective, and environmentally friendly. Intermeccanica, a subsidiary of Electra Meccanica, has successfully been building high-end specialty cars for 60 years. For more information, visit www.electrameccanica.com.
|
|
| |
|
| |
| Quote of the Week |
| |
"When no one wants the stock, that's often the best time to buy. Some of my best institutions buy when everything is out of favor."
- Byron Roth CEO of ROTH Capital Partners |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
|
|
|
|
